pmc logo image
Logo of iaiInfect Immun SubscriptionsInfect Immun Web Site

Formats:

Infect Immun. 1984 December; 46(3): 747–753.
PMCID: PMC261608
Predisposing factors in Pneumocystis carinii pneumonia: effects of tetracycline, protein malnutrition, and corticosteroids on hosts.
P D Walzer, M LaBine, T J Redington, and M T Cushion
Abstract
Components of the immunosuppressive regimen used to reactivate latent Pneumocystis carinii infection were analyzed for their effects on the growth, nutrition, and lymphoid system of hosts. Rats that were administered either tetracycline or a low-protein (8%) diet alone for 7 weeks developed few abnormalities, but animals on the combined regimen developed lower body and lymphoid organ weights, lower serum albumin levels, and fewer circulating lymphocytes. Rats that were administered corticosteroids and tetracycline experienced severe wasting, debilitation, and generalized lymphocyte depletion; the low-protein diet increased the magnitude of these changes. Alterations in the frequency of occurrence of specific lymphocyte subsets occurred only in rats given corticosteroids and consisted mainly of a greater decline in peripheral blood T helper cells than in T suppressor cells. The data suggest that long-term tetracycline administration and a low-protein diet have a variety of adverse effects on the host which enhance the immunosuppressive properties of corticosteroids.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Belsheim J, Gnarpe H, Persson S. Tetracyclines and host defense mechanisms: interference with leukocyte chemotaxis. Scand J Infect Dis. 1979;11(2):141–145. [PubMed]
  • Chandra RK. Cell-mediated immunity in nutritional imbalance. Fed Proc. 1980 Nov;39(13):3088–3092. [PubMed]
  • Cushion MT, Walzer PD. Growth and serial passage of Pneumocystis carinii in the A549 cell line. Infect Immun. 1984 May;44(2):245–251. [PubMed]
  • Fauci AS. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. Immunology. 1975 Apr;28(4):669–680. [PubMed]
  • Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, Gelmann EP. NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med. 1984 Jan;100(1):92–106. [PubMed]
  • Forsgren A, Schmeling D, Quie PG. Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis. 1974 Oct;130(4):412–415. [PubMed]
  • Frenkel JK, Good JT, Shultz JA. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966 Oct;15(10):1559–1577. [PubMed]
  • Gottschall JL, Walzer PD, Yoneda K. The morphologic changes of the rat type II pneumocytes induced by oxytetracycline. Lab Invest. 1979 Jul;41(1):5–12. [PubMed]
  • Hermann LM, White WJ, Lang CM. Prolonged exposure to acid, chlorine, or tetracycline in the drinking water: effects on delayed-type hypersensitivity, hemagglutination titers, and reticuloendothelial clearance rates in mice. Lab Anim Sci. 1982 Dec;32(6):603–608. [PubMed]
  • Herrod HG, Valenski WR, Woods DR, Pifer LL. The in vitro response of human lymphocytes to Pneumocystis carinii antigen. J Immunol. 1981 Jan;126(1):59–61. [PubMed]
  • Hughes WT, Kim HK, Price RA, Miller C. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr Ther Res Clin Exp. 1973 Aug;15(8):581–587. [PubMed]
  • Hughes WT, Price RA, Sisko F, Havron WS, Kafatos AG, Schonland M, Smythe PM. Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection. Am J Dis Child. 1974 Jul;128(1):44–52. [PubMed]
  • Lunn PG, Whitehead RG, Baker BA, Austin S. The effect of cortisone acetate on the course of development of experimental protein-energy malnutrition in rats. Br J Nutr. 1976 Nov;36(3):537–550. [PubMed]
  • Markowitz SM, Sobieski T, Martinez AJ, Duma RJ. Experimental Acanthamoeba infections in mice pretreated with methylprednisolone or tetracycline. Am J Pathol. 1978 Sep;92(3):733–744. [PubMed]
  • Martin RR, Warr GA, Couch RB, Yeager H, Knight V. Effects of tetracycline on leukotaxis. J Infect Dis. 1974 Feb;129(2):110–116. [PubMed]
  • Masur H, Jones TC. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med. 1978 Jan 1;147(1):157–170. [PubMed]
  • Meuwissen JH, Tauber I, Leeuwenberg AD, Beckers PJ, Sieben M. Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis. 1977 Jul;136(1):43–49. [PubMed]
  • Milder JE, Walzer PD, Coonrod JD, Rutledge ME. Comparison of histological and immunological techniques for detection of Pneumocystis carinii in rat bronchial lavage fluid. J Clin Microbiol. 1980 Apr;11(4):409–417. [PubMed]
  • Pesanti EL. Effects of bacterial pneumonitis on development of pneumocystosis in rats. Am Rev Respir Dis. 1982 Jun;125(6):723–726. [PubMed]
  • SHELDON WH. Experimental pulmonary Pneumocystis carinii infection in rabbits. J Exp Med. 1959 Jul 1;110(1):147–160. [PubMed]
  • Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med. 1983 Mar;101(3):479–487. [PubMed]
  • Thong YH, Ferrante A. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol. 1979 Mar;35(3):443–446. [PubMed]
  • Thong YH, Ferrante A. Effect of tetracycline treatment on immunological responses in mice. Clin Exp Immunol. 1980 Mar;39(3):728–732. [PubMed]
  • Van den Bogert C, Kroon AM. Effects of oxytetracycline on in vivo proliferation and differentiation of erythroid and lymphoid cells in the rat. Clin Exp Immunol. 1982 Nov;50(2):327–335. [PubMed]
  • Von Behren LA, Pesanti EL. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis. 1978 Dec;118(6):1051–1059. [PubMed]
  • Walzer PD, LaBine M, Redington TJ, Cushion MT. Lymphocyte changes during chronic administration of and withdrawal from corticosteroids: relation to Pneumocystis carinii pneumonia. J Immunol. 1984 Nov;133(5):2502–2508. [PubMed]
  • Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med. 1974 Jan;80(1):83–93. [PubMed]
  • Walzer PD, Powell RD, Jr, Yoneda K, Rutledge ME, Milder JE. Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia. Infect Immun. 1980 Mar;27(3):928–937. [PubMed]
  • Walzer PD, Rutledge ME. Serum antibody responses to Pneumocystis carinii among different strains of normal and athymic mice. Infect Immun. 1982 Feb;35(2):620–626. [PubMed]
  • Walzer PD, Rutledge ME. Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats. J Lab Clin Med. 1981 Jun;97(6):820–833. [PubMed]
  • Walzer PD, Schnelle V, Armstrong D, Rosen PP. Nude mouse: a new experimental model for Pneumocystis carinii infection. Science. 1977 Jul 8;197(4299):177–179. [PubMed]
  • Yoneda K, Walzer PD. Interaction of Pneumocystis carinii with host lungs: an ultrastructural study. Infect Immun. 1980 Aug;29(2):692–703. [PubMed]